Literature DB >> 27409073

Ibrutinib penetrates the blood brain barrier and shows efficacy in the therapy of Bing Neel syndrome.

Christopher Mason1, Steven Savona1, Josephine N Rini2,3, Jorge J Castillo4, Lian Xu4, Zachary R Hunter4, Steven P Treon4, Steven L Allen1.   

Abstract

Entities:  

Keywords:  Bing Neel syndrome; CXCR4; MYD88; Waldenström macroglobulinemia; ibrutinib

Mesh:

Substances:

Year:  2016        PMID: 27409073     DOI: 10.1111/bjh.14218

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  21 in total

1.  Rare case of Bing-Neel syndrome treated successfully with ibrutinib.

Authors:  Hamza Hashmi; Jugraj Singh Dhanoa; Robert Emmons
Journal:  BMJ Case Rep       Date:  2019-06-25

Review 2.  Primary central nervous system lymphoma: essential points in diagnosis and management.

Authors:  Semra Paydas
Journal:  Med Oncol       Date:  2017-03-17       Impact factor: 3.064

3.  Standard Dose of Ibrutinib is Effective in the Treatment of Bing-Neel Syndrome.

Authors:  Mark Plander; Tamás Szendrei; Árpád Vadvári; János Iványi
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

4.  Imaging spectrum of Bing-Neel syndrome: how can a radiologist recognise this rare neurological complication of Waldenström's macroglobulinemia?

Authors:  Aikaterini Fitsiori; Luc-Matthieu Fornecker; Laurence Simon; Alexandros Karentzos; Damien Galanaud; Olivier Outteryck; Patrick Vermersch; Jean-Pierre Pruvo; Emmanuel Gerardin; Christine Lebrun-Frenay; Francois Lafitte; Jean-Philippe Cottier; Christine Clerc; Jerome de Seze; Jean-Louis Dietemann; Stephane Kremer
Journal:  Eur Radiol       Date:  2018-06-19       Impact factor: 5.315

5.  First-line ibrutinib for Bing-Neel syndrome.

Authors:  Aaron Tallant; Daniel Selig; Sam O Wanko; Joseph Roswarski
Journal:  BMJ Case Rep       Date:  2018-10-02

6.  Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome.

Authors:  Monique C Minnema; Eva Kimby; Shirley D'Sa; Luc-Matthieu Fornecker; Stéphanie Poulain; Tom J Snijders; Efstathios Kastritis; Stéphane Kremer; Aikaterini Fitsiori; Laurence Simon; Frédéric Davi; Michael Lunn; Jorge J Castillo; Christopher J Patterson; Magali Le Garff-Tavernier; Myrto Costopoulos; Véronique Leblond; Marie-José Kersten; Meletios A Dimopoulos; Steven P Treon
Journal:  Haematologica       Date:  2016-10-06       Impact factor: 9.941

7.  Treatment Sequencing in a Chronic Lymphocytic Leukemia Patient with Central Nervous System Involvement.

Authors:  Filipa Mousinho; Tatiana Mendes; Paula Sousa E Santos; Maria João Acosta; José Pereira; Maria Arroz; Cândido Silva; Ana Paula Azevedo; Rita Oliveira; Martinha Chorão; Fernando Lima
Journal:  Case Rep Hematol       Date:  2018-05-27

Review 8.  Bing-Neel Syndrome: Illustrative Cases and Comprehensive Review of the Literature.

Authors:  Marzia Varettoni; Irene Defrancesco; Luca Diamanti; Enrico Marchioni; Lisa Maria Farina; Anna Pichiecchio
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-10-18       Impact factor: 2.576

Review 9.  [Bing-Neel syndrome: 3 cases report and a review of the literature].

Authors:  Y Y Mao; X X Cao; H Cai; D B Zhou; J Li
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-12-14

10.  Successful Treatment of Chronic Lymphocytic Leukemia Multifocal Central Nervous System Involvement with Ibrutinib.

Authors:  Anna Christoforidou; Georgios Kapsas; Zoe Bezirgiannidou; Spyros Papamichos; Ιoannis Kotsianidis
Journal:  Turk J Haematol       Date:  2018-02-02       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.